Lonza buys Belgian CRO Algonomics
This article was originally published in Scrip
Executive Summary
Just days after calling off its planned acquisition of Patheon, reducing earnings guidance and announcing cost-cutting plans, Lonza has acquired the Belgian biotech contract research organisation, Algonomics. The price paid was not disclosed. Algonomics strengthens Lonza in protein design technology.